CIK 0001714899 · Large accelerated filer
Denali Therapeutics Inc.
Sign in to watch- Ticker
- DNLI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463872213
- Phone
- (650) 866-8547
- Business address
- 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $363,678
- in 3 filings, $327K under 10b5-1 plans
Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-02-04 | Ho Carole Chief Medical Officer | Sale | −3,100 | $18.49 | $57K | 769 |
| 2019-02-04 | Ho Carole Chief Medical Officer | Sale | −769 | $19.11 | $15K | 0 |
| 2019-02-04 | Ho Carole Chief Medical Officer | Option exercise · Stock Option (right to buy) | −730 | 95,880 | ||
| 2019-02-04 | Ho Carole Chief Medical Officer | Option exercise · Stock Option (right to buy) | −3,139 | 137,486 | ||
| 2019-02-04 | Watts Ryan J. President and CEO | Sale | −3,200 | $18.49 | $59K | 2,643,388 |
| 2019-02-04 | Watts Ryan J. President and CEO | Sale | −854 | $19.12 | $16K | 2,642,534 |
| 2019-02-01 | Ho Carole Chief Medical Officer | Option exercise | +5,775 | $5.28 | $30K | 5,775 |
| 2019-02-01 | Ho Carole Chief Medical Officer | Sale | −5,775 | $18.64 | $108K | 0 |
| 2019-02-01 | Ho Carole Chief Medical Officer | Option exercise · Stock Option (right to buy) | −5,775 | 96,610 | ||
| 2019-02-01 | Watts Ryan J. President and CEO | Sale | −6,050 | $18.65 | $113K | 2,646,588 |
| 2019-01-11 | Schuth Alexander O. COO and Secretary | Sale | −2,500 | $20.80 | $52K | 670,089 |
| 2019-01-10 | Schuth Alexander O. COO and Secretary | Sale | −2,500 | $19.99 | $50K | 672,589 |
| 2019-01-09 | Schuth Alexander O. COO and Secretary | Sale | −2,500 | $20.31 | $51K | 675,089 |
| 2019-01-04 | Ho Carole Chief Medical Officer | Option exercise | +5,950 | $5.28 | $31K | 184,075 |
| 2019-01-04 | Ho Carole Chief Medical Officer | Sale | −1,500 | $19.30 | $29K | 182,575 |
| 2019-01-04 | Ho Carole Chief Medical Officer | Sale | −4,450 | $20.03 | $89K | 178,125 |
| 2019-01-04 | Ho Carole Chief Medical Officer | Option exercise · Stock Option (right to buy) | −5,950 | 66,875 | ||
| 2019-01-04 | Ho Carole Chief Medical Officer | Option exercise | +5,950 | $5.28 | $31K | 8,727 |
| 2019-01-04 | Ho Carole Chief Medical Officer | Sale | −1,500 | $19.30 | $29K | 7,227 |
| 2019-01-04 | Ho Carole Chief Medical Officer | Sale | −4,450 | $20.03 | $89K | 2,777 |
Page 44 of 53 · 1,053 trades